Nick Dyson

His primary areas of investigation include Retinoblastoma protein, E2F, Transcription factor, Molecular biology and Cell biology. His Retinoblastoma protein study integrates concerns from other disciplines, such as Mutation, Retinoblastoma-like protein 1, Tumor suppressor gene and E2F1. His research integrates issues of Retinoblastoma and Plasma protein binding in his study of E2F.

His Transcription factor research includes elements of Regulation of gene expression and Cancer research. His Molecular biology study combines topics from a wide range of disciplines, such as Retinoblastoma-Like Protein p107, Binding domain, Mutant, Cyclin A and Gene product. His work deals with themes such as DNA replication factor CDT1, DNA replication, Eukaryotic DNA replication and Cell Cycle Protein, which intersect with Cell biology.

Education

• Doctor of Philosophy - PhD The University of Manchester (1982.09 — 1988.06)
• Bachelor of Science - BS University of York (1979.10 — 1982.06)

Companies

• Professor in Medicine MGH Cancer Center and Harvard Medical School (2003)
• Scientific Director MGH Cancer Center (2012 — 2020)
• Associate Professor in Medicine MGH Cancer Center and Harvard Medical School (1998 — 2003)
• Assistant Professor in Medicine MGH Cancer Center and Harvard Medical School (1991 — 1998)
• Visiting Researcher Cold Spring Harbor Laboratory (1988 — 1990)
• Research And Development Scientist Amersham International (1985 — 1990)